Dr. Makoto Suematsu is the President of the Japan Agency for Medical Research and Development (AMED). AMED was established in 2015 to progress medical innovation and overcome barriers between sectors by connecting talented individuals and groups with each other. Dr. Suematsu has led AMED to enter Memorandum of Cooperation agreements with several of their counterparts including the United States of America, the United Kingdom, Singapore, Spain, Australia and Lithuania. Dr. Suematsu also represents Japan on a number of overseas institutions and global consortiums including the International Rare Diseases Research Consortium, Global Research Collaboration for Infectious Disease Preparedness, Joint Programming Initiative on Antimicrobial Resistance and the International Human Epigenome Consortium.